Tech Company Financing Transactions
Renovion Funding Round
On 6/22/2020, Renovion landed $8.1 million in Series A financing from WhiteRock Capital Partners and private investors.
Transaction Overview
Company Name
Announced On
6/22/2020
Transaction Type
Venture Equity
Amount
$8,100,000
Round
Series A
Investors
WhiteRock Capital Partners (Lead Investor) (Thomas Barton)
Proceeds Purpose
This funding will be instrumental in progressing our clinical programs in patients suffering from chronic lung diseases, including patients with a lung transplant, cystic fibrosis (CF), and non-CF bronchiectasis.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
900 MLK Jr. Blvd. A
Chapel Hill, NC 27514
USA
Chapel Hill, NC 27514
USA
Phone
Undisclosed
Website
Email Address
Overview
Renovion is a clinical stage pharmaceutical company with a nebulized therapy that restores mucus clearance and reduces inflammation in the lungs. The company is focused on developing ARINA-1 for orphan chronic inflammatory lung diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daniel Copeland
Chief Scientific Officer
Carolyn Durham
Browse more venture capital transactions:
Prev: 6/22/2020: Surrozen venture capital transaction
Next: 6/22/2020: Plume venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs